FL

Francesco Lavino

Chief Executive Officer

F2G

New York, New York


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
F2G
Industry
research
Employees
95.0
Seniority
C suite
Annual Revenue
110000000.0
Website
Total Funding
348164400.0
Latest Funding
Series H

Technologies

Mimecast Outlook Microsoft Office 365 Nginx WordPress.org Google Font API Mobile Friendly Apache Remote

Keywords

biotechnology life sciences biotechnology research antifungal fungal infections life-threatening infections rare fungal infections invasive fungal infections drug discovery clinical trials molecular biology biochemistry therapeutic potential innovative science genomic technology asymptomatic patient-first antifungal resistance coccidioides aspergillus microbiology therapeutic options fda breakthrough therapy designation orphan drug status clinical data patient population fungal pathogens small-molecule inhibitors target screening chemical series therapies vulnerable patients diagnosis immunocompromised individuals pharmaceuticals research & development commercialization healthcare pathophysiology investigational therapies fda approval patient care drug development life-saving therapies clinical effectiveness health challenges biopharmaceutical industry partnerships health care health wellness & fitness hospital & health care medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans